Publication | Open Access

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

VaccinationVaccine DevelopmentVaccine TargetImmunologyProduction ProcessVirologySars Vaccine CandidateVaccine DesignMedicineBroad-spectrum Vaccines